Description

The Tumor Test Marker YRA385 // YRA391 is an advanced diagnostic kit specifically crafted for chemiluminescence immunoassay (CLIA) analyzers. This comprehensive test kit is capable of detecting 18 different tumor markers, making it a crucial tool in the early detection of cancer. By identifying elevated levels of tumor markers in blood samples, it facilitates the diagnosis and differentiation of various malignant tumors, providing reliable support to healthcare professionals in tailoring treatment plans.

Market Price

The pricing for the Tumor Test Marker YRA385 // YRA391 can vary depending on the supplier and geographical location. Typically, these test kits are available within the range of $300 to $500 per box. Prices might fluctuate based on bulk purchase discounts or added logistical costs. For the latest pricing information, it is advisable to request a quotation directly from the supplier.

Frequently Asked Questions

What is included in the test kit? Each kit contains the necessary reagents and components to perform tests for all listed tumor markers using CLIA analysis.

How many tests can be performed with one kit? Depending on the package specification, the kits are available in options of 50T/BOX, 100T/BOX, and 24T/BOX.

What certifications does this product have? The Tumor Test Marker Kit is certified with CE, ISO13485, and FSC, ensuring compliance with international quality standards.

Advantages and Disadvantages

One of the main advantages of the Tumor Test Marker YRA385 // YRA391 is its ability to detect multiple tumor markers simultaneously, which enhances diagnostic accuracy and efficiency. Its robustness in early cancer detection is invaluable. However, one potential drawback could be the initial cost, which might be high for smaller practices. Additionally, handling and storage at 2-8°C require appropriate facilities.

Use in the Field

In practical scenarios, this test kit is typically used in hospitals and diagnostic laboratories. It helps oncologists and medical practitioners in the early detection of cancers, enabling timely intervention and improved patient prognosis. The CLIA technology ensures precise and reliable results, supporting comprehensive cancer care.

Recommendations

To maximize the utility and lifespan of the test kits, it’s recommended to adhere strictly to the storage conditions between 2-8°C. Ensure regular calibration of the CLIA analyzer for accurate results and consult the user manual for correct test procedures. For streamlined operations, consider enrolling in the Kalstein Plus platform to automate your procurement process and enjoy priority access to technical support and product updates.

Features

• Detects 18 different tumor markers.
• Supports early cancer detection.
• Compatible with CLIA analyzers.
• Available in multiple package specifications.
• Comes with CE, ISO13485, and FSC certifications.

Technical Specifications